RT Journal Article
T1 European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
A1 Stratigos, Alexander J
A1 Garbe, Claus
A1 Dessinioti, Clio
A1 Lebbe, Celeste
A1 Bataille, Veronique
A1 Bastholt, Lars
A1 Dreno, Brigitte
A1 Fargnoli, Maria Concetta
A1 Forsea, Ana Maria
A1 Frenard, Cecille
A1 Harwood, Catherine Α
A1 Hauschild, Axel
A1 Hoeller, Christoph
A1 Kandolf-Sekulovic, Lidija
A1 Kaufmann, R
A1 Kelleners-Smeets, Nicole Wj
A1 Malvehy, Josep
A1 Del Marmol, Veronique
A1 Middleton, Mark R
A1 Moreno-Ramirez, David
A1 Pellecani, Giovanni
A1 Peris, Ketty
A1 Saiag, Philippe
A1 van den Beuken-van Everdingen, Marieke H J
A1 Vieira, Ricardo
A1 Zalaudek, Iris
A1 Eggermont, Alexander M M
A1 Grob, Jean-Jacques
A1 European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)
K1 Diagnosis
K1 High-risk common primary cSCC
K1 Imaging
K1 Invasive cutaneous squamous cell carcinoma
K1 Locally advanced Cscc
K1 Low-risk
K1 Metastatic cSCC
K1 Prevention
K1 Prognosis
K1 Staging
AB Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex, immunosuppression, smoking and genetic factors. A collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation of Research and Treatment of Cancer (EORTC) was formed to update recommendations on cSCC classification, diagnosis, risk stratification, staging and prevention, based on current literature, staging systems and expert consensus. Common cSCCs are typically indolent tumors, and most have a good prognosis with 5-year cure rates of greater than 90%, and a low rate of metastases (
YR 2020
FD 2020-02-26
LK http://hdl.handle.net/10668/15183
UL http://hdl.handle.net/10668/15183
LA en
DS RISalud
RD Apr 15, 2025